CytomX Therapeutics Statistics
Total Valuation
CTMX has a market cap or net worth of $107.53 million. The enterprise value is -$30.80 million.
| Market Cap | 107.53M |
| Enterprise Value | -30.80M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CTMX has 77.92 million shares outstanding. The number of shares has increased by 24.73% in one year.
| Shares Outstanding | 77.92M |
| Shares Change (YoY) | +24.73% |
| Shares Change (QoQ) | +1.32% |
| Owned by Insiders (%) | 0.95% |
| Owned by Institutions (%) | 72.57% |
| Float | 58.39M |
Valuation Ratios
The trailing PE ratio is 6.90 and the forward PE ratio is 53.76. CTMX's PEG ratio is -1.80.
| PE Ratio | 6.90 |
| Forward PE | 53.76 |
| PS Ratio | 0.90 |
| Forward PS | 1.40 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | -1.80 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.16
| Current Ratio | 1.16 |
| Quick Ratio | 1.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.49 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -30.70% and return on invested capital (ROIC) is -46.48%.
| Return on Equity (ROE) | -30.70% |
| Return on Assets (ROA) | 8.10% |
| Return on Capital (ROIC) | -46.48% |
| Revenue Per Employee | $976,869 |
| Profits Per Employee | $135,516 |
| Employee Count | 122 |
| Asset Turnover | 0.58 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CTMX has paid $3.94 million in taxes.
| Income Tax | 3.94M |
| Effective Tax Rate | 19.25% |
Stock Price Statistics
The stock price has decreased by -24.18% in the last 52 weeks. The beta is 1.06, so CTMX's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -24.18% |
| 50-Day Moving Average | 1.61 |
| 200-Day Moving Average | 1.69 |
| Relative Strength Index (RSI) | 45.83 |
| Average Volume (20 Days) | 1,331,985 |
Short Selling Information
The latest short interest is 8.05 million, so 10.33% of the outstanding shares have been sold short.
| Short Interest | 8.05M |
| Short Previous Month | 7.76M |
| Short % of Shares Out | 10.33% |
| Short % of Float | 13.79% |
| Short Ratio (days to cover) | 3.53 |
Income Statement
In the last 12 months, CTMX had revenue of $119.18 million and earned $16.53 million in profits. Earnings per share was $0.20.
| Revenue | 119.18M |
| Gross Profit | 119.18M |
| Operating Income | 10.83M |
| Pretax Income | 20.47M |
| Net Income | 16.53M |
| EBITDA | 26.34M |
| EBIT | 20.47M |
| Earnings Per Share (EPS) | $0.20 |
Balance Sheet
The company has $151.20 million in cash and $12.87 million in debt, giving a net cash position of $138.33 million or $1.78 per share.
| Cash & Cash Equivalents | 151.20M |
| Total Debt | 12.87M |
| Net Cash | 138.33M |
| Net Cash Per Share | $1.78 |
| Equity (Book Value) | -31.68M |
| Book Value Per Share | -0.41 |
| Working Capital | 22.71M |
Cash Flow
In the last 12 months, operating cash flow was -$91.43 million and capital expenditures -$907,000, giving a free cash flow of -$92.34 million.
| Operating Cash Flow | -91.43M |
| Capital Expenditures | -907,000 |
| Free Cash Flow | -92.34M |
| FCF Per Share | -$1.13 |
Margins
Gross margin is 100.00%, with operating and profit margins of 9.08% and 13.87%.
| Gross Margin | 100.00% |
| Operating Margin | 9.08% |
| Pretax Margin | 17.18% |
| Profit Margin | 13.87% |
| EBITDA Margin | 22.10% |
| EBIT Margin | 17.18% |
| FCF Margin | -77.48% |
Dividends & Yields
CTMX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.73% |
| Shareholder Yield | -24.73% |
| Earnings Yield | 15.38% |
| FCF Yield | -85.87% |
Analyst Forecast
The average price target for CTMX is $5.77, which is 318.12% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.77 |
| Price Target Difference | 318.12% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 0.87% |
| EPS Growth Forecast (5Y) | 52.17% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTMX has an Altman Z-Score of -3.92 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.92 |
| Piotroski F-Score | 4 |